Mapping of TLR5 and TLR7 in central and distal human airways and identification of reduced TLR expression in severe asthma

Clinical and Experimental Allergy

Volumn 44, Issue 2, 2014, Pages 184-196

  Shikhagaie, M M ^a   Andersson, C K ^b   Mori, M ^a   Kortekaas Krohn, I ^c   Bergqvist, A ^b   Dahl, R ^c   Ekblad, E ^a   Hoffmann, H J ^c   Bjermer, L ^b   Erjefalt J S ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Asthma; Severe asthma; TLR5; TLR7

Indexed keywords

BUDESONIDE; PREDNISOLONE; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7;

ADULT; ARTICLE; ASTHMA; BASOLATERAL MEMBRANE; BRONCHUS BIOPSY; BRONCHUS MUCOSA; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG ALVEOLUS CELL; LUNG FUNCTION; MACROPHAGE; MALE; NEUTROPHIL; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSBRONCHIAL BIOPSY; YOUNG ADULT;

ASTHMA; SEVERE ASTHMA; TLR5; TLR7;

ADULT; AGED; ASTHMA; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LUNG; MALE; MIDDLE AGED; RESPIRATORY MUCOSA; SEVERITY OF ILLNESS INDEX; TOLL-LIKE RECEPTOR 5; TOLL-LIKE RECEPTOR 7;

EID: 84892749900     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12176     Document Type: Article

References (52)

1. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008; 8:183-92.
2. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med 2001; 344:350-62.
3. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012; 18:716-25.
4. Lotvall J, Akdis CA, Bacharier LB et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol 2011; 127:355-60.
5. Holt PG, Sly PD. Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment. Nat Med 2012; 18:726-35.
6. Hansel TT, Johnston SL, Openshaw PJ. Microbes and mucosal immune responses in asthma. Lancet 2013; 381:861-73.
7. Elinav E, Strowig T, Henao-Mejia J, Flavell RA. Regulation of the antimicrobial response by NLR proteins. Immunity 2011; 34:665-79.
8. Kumar H, Kawai T, Akira S. Toll-like receptors and innate immunity. Biochem Biophys Res Commun 2009; 388:621-5.
9. Lambrecht BN, Hammad H. The airway epithelium in asthma. Nat Med 2012; 18:684-92.
10. Atmar RL, Guy E, Guntupalli KK et al. Respiratory tract viral infections in inner-city asthmatic adults. Arch Intern Med 1998; 158:2453-9.
11. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004; 303:1529-31.
12. Johnston SL, Pattemore PK, Sanderson G et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med 1996; 154(3 Pt 1):654-60.
13. Lund JM, Alexopoulou L, Sato A et al. Recognition of single-stranded RNA viruses by toll-like receptor 7. Proc Natl Acad Sci USA 2004; 101:5598-603.
14. Moller-Larsen S, Nyegaard M, Haagerup A, Vestbo J, Kruse TA, Borglum AD. Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders. Thorax 2008; 63:1064-9.
15. Roponen M, Yerkovich ST, Hollams E, Sly PD, Holt PG, Upham JW. Toll-like receptor 7 function is reduced in adolescents with asthma. Euro Respir J Official J Euro Soc Clin Respiratory Physiol 2010; 35:64-71.
16. Kaufman EH, Jacoby DB. Upping the antedrug: is a novel anti-inflammatory toll-like receptor 7 agonist also a bronchodilator? Br J Pharmacol 2012; 166:569-72.
17. Drake MG, Kaufman EH, Fryer AD, Jacoby DB. The therapeutic potential of toll-like receptor 7 stimulation in asthma. Inflamm Allergy Drug Targets 2012; 11:484-91.
18. Matsui H, Tomizawa H, Eiho K et al. Mechanism of action of inhibition of allergic immune responses by a novel antedrug TLR7 agonist. J Immunol 2012; 189:5194-205.
19. Kaufman EH, Fryer AD, Jacoby DB. Toll-like receptor 7 agonists are potent and rapid bronchodilators in guinea pigs. J Allergy Clin Immunol 2011; 127:462-9.
20. Du Q, Zhou LF, Chen Z, Gu XY, Huang M, Yin KS. Imiquimod, a toll-like receptor 7 ligand, inhibits airway remodelling in a murine model of chronic asthma. Clin Exp Pharmacol Physiol 2009; 36:43-8.
21. Greiff L, Cervin A, Ahlstrom-Emanuelsson C et al. Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis. Respir Res 2012; 13:53.
22. Xirakia C, Koltsida O, Stavropoulos A et al. Toll-like receptor 7-triggered immune response in the lung mediates acute and long-lasting suppression of experimental asthma. Am J Respir Crit Care Med 2010; 181:1207-16.
23. Chignard M, Balloy V, Sallenave JM, Si-Tahar M. Role of toll-like receptors in lung innate defense against invasive aspergillosis. Distinct impact in immunocompetent and immunocompromized hosts. Clin Immunol 2007; 124:238-43.
24. Descamps D, Le Gars M, Balloy V et al. Toll-like receptor 5 (TLR5), IL-1beta secretion, and asparagine endopeptidase are critical factors for alveolar macrophage phagocytosis and bacterial killing. Proc Natl Acad Sci USA 2012; 5:1619-24.
25. Feuillet V, Medjane S, Mondor I et al. Involvement of toll-like receptor 5 in the recognition of flagellated bacteria. Proc Natl Acad Sci USA 2006; 103:12487-92.
26. Raoust E, Balloy V, Garcia-Verdugo I, Touqui L, Ramphal R, Chignard M. Pseudomonas aeruginosa LPS or flagellin are sufficient to activate TLR-dependent signaling in murine alveolar macrophages and airway epithelial cells. PLoS ONE 2009; 4:e7259.
27. Wilson RH, Maruoka S, Whitehead GS et al. The toll-like receptor 5 ligand flagellin promotes asthma by priming allergic responses to indoor allergens. Nat Med 2012; 18:1705-10.
28. Kraft M. Part III: Location of asthma inflammation and the distal airways: clinical implications. Curr Med Res Opin 2007; 23(Suppl 3):S21-7.
29. Andersson CK, Bergqvist A, Mori M, Mauad T, Bjermer L, Erjefalt JS. Mast cell-associated alveolar inflammation in patients with atopic uncontrolled asthma. J Allergy Clin Immunol 2011; 127:905-12.
30. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987;136:225-44.
31. Tufvesson E, Aronsson D, Ankerst J, George SC, Bjermer L. Peripheral nitric oxide is increased in rhinitic patients with asthma compared to bronchial hyperresponsiveness. Respir Med 2007; 101:2321-6.
32. Barajon I, Serrao G, Arnaboldi F et al. Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia. J Histochem Cytochem 2009; 57:1013-23.
33. Carpentier PA, Duncan DS, Miller SD. Glial toll-like receptor signaling in central nervous system infection and autoimmunity. Brain Behav Immun 2008; 22:140-7.
34. Andersson CK, Mori M, Bjermer L, Lofdahl CG, Erjefalt JS. Novel site-specific mast cell subpopulations in the human lung. Thorax 2009; 64:297-305.
35. Kanagaratham C, Camateros P, Flaczyk A, Radzioch D. Polymorphisms in TOLL-like receptor genes and their roles in allergic asthma and atopy. Recent Pat Inflamm Allergy Drug Discov 2011; 5:45-56.
36. Kovach MA, Standiford TJ. Toll like receptors in diseases of the lung. Int Immunopharmacol 2011; 11:1399-406.
37. Homma T, Kato A, Hashimoto N et al. Corticosteroid and cytokines synergistically enhance toll-like receptor 2 expression in respiratory epithelial cells. Am J Respir Cell Mol Biol 2004; 31:463-9.
38. Schleimer RP. Glucocorticoids suppress inflammation but spare innate immune responses in airway epithelium. Proc Am Thorac Soc 2004; 1:222-30.
39. MacRedmond RE, Greene CM, Dorscheid DR, McElvaney NG, O'Neill SJ. Epithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smoke. Respir Res 2007; 8:84.
40. Habibzay M, Saldana JI, Goulding J, Lloyd CM, Hussell T. Altered regulation of toll-like receptor responses impairs antibacterial immunity in the allergic lung. Mucosal Immunol 2012; 5:524-34.
41. Pasternack R, Huhtala H, Karjalainen J. Chlamydophila (Chlamydia) pneumoniae serology and asthma in adults: a longitudinal analysis. J Allergy Clin Immunol 2005; 116:1123-8.
42. Sevin CM, Peebles RS Jr. Infections and asthma: new insights into old ideas. Clin Exp Allergy 2010; 40:1142-54.
43. Wark P, Tooze M, Powell H, Parsons K. Viral and bacterial infection in acute asthma & chronic obstructive pulmonary disease increases the risk of readmission. Respirology 2013;18:996-1002.
44. Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001; 2:947-50.
45. Lehnardt S. Innate immunity and neuroinflammation in the CNS: the role of microglia in toll-like receptor-mediated neuronal injury. Glia 2010; 58:253-63.
46. Gewirtz AT, Navas TA, Lyons S, Godowski PJ, Madara JL. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 2001; 167:1882-5.
47. Adamo R, Sokol S, Soong G, Gomez MI, Prince A. Pseudomonas aeruginosa flagella activate airway epithelial cells through asialoGM1 and toll-like receptor 2 as well as toll-like receptor 5. Am J Respir Cell Mol Biol 2004; 30:627-34.
48. Chuquimia OD, Petursdottir DH, Rahman MJ, Hartl K, Singh M, Fernandez C. The role of alveolar epithelial cells in initiating and shaping pulmonary immune responses: communication between innate and adaptive immune systems. PLoS ONE 2012; 7:e32125.
49. Fehrenbach K, Port F, Grochowy G et al. Stimulation of mast cells via FcvarepsilonR1 and TLR2: the type of ligand determines the outcome. Mol Immunol 2007; 44:2087-94.
50. Hochdorfer T, Kuhny M, Zorn CN et al. Activation of the PI3K pathway increases TLR-induced TNF-alpha and IL-6 but reduces IL-1beta production in mast cells. Cell Signal 2011; 23:866-75.
51. Lambrecht BN, Hammad H. The role of dendritic and epithelial cells as master regulators of allergic airway inflammation. Lancet 2010; 376:835-43.
52. Kadowaki N, Ho S, Antonenko S et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001; 194:863-9.